Acomplia the New Weight Loss Pill from Sanofi-Aventis
June 28 Sanofi-Aventis launched the newest weight management medication on the market - Acomplia (rimonabant)
London, England (PRWEB) July 26, 2006
For most of us the quest to lose weight has really become a struggle for many reasons. One of the biggest reasons most of us are gaining too much weight and can't seem to lose it is because we eat way too much fast food. Due to our busy schedules that has us always on the run, fast food has become very convenient for a great deal of us, which more often then not is unhealthy. Also lets face it, good tasting foods have become very addictive for many of us. When we go out to eat it is hard for most of us to choose the healthier choices rather then the better tasting foods.
Have you tried weight loss diet pills? If they didn't work for you do you wonder if there are some better diet products out there that are actually helping people to lose weight safely without giving up all of their favorite foods?
Acomplia (Rimonabant)- It works by blocking endogenous cannabinoid binding to neuronal CB1 receptors. Activation of these receptors by endoegenous cannabinoids, such as anadamide, increases appetite. It is the only endocannabinoid receptor antagonist now on the market and thus offers a unique therapeutic approach to appetite control and weight reduction.
Obesity is now the most common nutritional disorder in western industrialised countries. Defined as a body mass index of greater than 30, it arises from the accumulation of excess fat in the body from overconsumption of fatty foods.
Asset Chemist
38 Grovebury Road, London
###
